Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Related Citations for PubMed (Select 12925681)

1.

DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, Hakola P, Haltia M, Konttinen YT, Peltonen L.

J Exp Med. 2003 Aug 18;198(4):669-75.

2.

TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.

Humphrey MB, Daws MR, Spusta SC, Niemi EC, Torchia JA, Lanier LL, Seaman WE, Nakamura MC.

J Bone Miner Res. 2006 Feb;21(2):237-45. Epub 2005 Oct 20.

PMID:
16418779
3.

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.

Klünemann HH, Ridha BH, Magy L, Wherrett JR, Hemelsoet DM, Keen RW, De Bleecker JL, Rossor MN, Marienhagen J, Klein HE, Peltonen L, Paloneva J.

Neurology. 2005 May 10;64(9):1502-7.

PMID:
15883308
4.

Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.

Bianchin MM, Capella HM, Chaves DL, Steindel M, Grisard EC, Ganev GG, da Silva Júnior JP, Neto Evaldo S, Poffo MA, Walz R, Carlotti Júnior CG, Sakamoto AC.

Cell Mol Neurobiol. 2004 Feb;24(1):1-24. Review.

PMID:
15049507
5.

Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.

Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, Tranebjaerg L, Konttinen Y, Peltonen L.

Am J Hum Genet. 2002 Sep;71(3):656-62. Epub 2002 Jun 21. Erratum in: Am J Hum Genet. 2003 Jan;72(1):225..

6.

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L.

Neurobiol Dis. 2005 Mar;18(2):314-22.

PMID:
15686960
7.

The signaling adapter protein DAP12 regulates multinucleation during osteoclast development.

Humphrey MB, Ogasawara K, Yao W, Spusta SC, Daws MR, Lane NE, Lanier LL, Nakamura MC.

J Bone Miner Res. 2004 Feb;19(2):224-34. Epub 2003 Dec 16.

PMID:
14969392
8.

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Paloneva J, Kestilä M, Wu J, Salminen A, Böhling T, Ruotsalainen V, Hakola P, Bakker AB, Phillips JH, Pekkarinen P, Lanier LL, Timonen T, Peltonen L.

Nat Genet. 2000 Jul;25(3):357-61.

PMID:
10888890
9.

Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.

Sessa G, Podini P, Mariani M, Meroni A, Spreafico R, Sinigaglia F, Colonna M, Panina P, Meldolesi J.

Eur J Neurosci. 2004 Nov;20(10):2617-28.

PMID:
15548205
10.

Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response.

Kiialainen A, Veckman V, Saharinen J, Paloneva J, Gentile M, Hakola P, Hemelsoet D, Ridha B, Kopra O, Julkunen I, Peltonen L.

J Mol Med (Berl). 2007 Sep;85(9):971-83. Epub 2007 May 26.

PMID:
17530208
11.

Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Cella M, Buonsanti C, Strader C, Kondo T, Salmaggi A, Colonna M.

J Exp Med. 2003 Aug 18;198(4):645-51. Epub 2003 Aug 11.

12.

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.

Bone. 2005 Jan;36(1):159-72. Epub 2004 Nov 24.

PMID:
15664014
13.

The enigmatic function of TREM-2 in osteoclastogenesis.

Colonna M, Turnbull I, Klesney-Tait J.

Adv Exp Med Biol. 2007;602:97-105. Review.

PMID:
17966394
14.

CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts.

Paloneva J, Autti T, Raininko R, Partanen J, Salonen O, Puranen M, Hakola P, Haltia M.

Neurology. 2001 Jun 12;56(11):1552-8.

PMID:
11402114
15.

TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB.

Sci Signal. 2010 May 18;3(122):ra38. doi: 10.1126/scisignal.2000500.

16.

Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.

Neumann H, Takahashi K.

J Neuroimmunol. 2007 Mar;184(1-2):92-9. Epub 2007 Jan 18. Review.

PMID:
17239445
17.

A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease.

Kuroda R, Satoh J, Yamamura T, Anezaki T, Terada T, Yamazaki K, Obi T, Mizoguchi K.

J Neurol Sci. 2007 Jan 15;252(1):88-91. Epub 2006 Nov 27.

PMID:
17125796
18.

No evidence for shared etiology in two demyelinative disorders, MS and PLOSL.

Sulonen AM, Kallio SP, Ellonen P, Suvela M, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Tienari PJ, Palotie A, Peltonen L, Saarela J.

J Neuroimmunol. 2009 Jan 3;206(1-2):86-90. doi: 10.1016/j.jneuroim.2008.10.005. Epub 2008 Nov 18.

19.

Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.

Satoh J, Shimamura Y, Tabunoki H.

Cell Mol Neurobiol. 2012 Apr;32(3):337-43. doi: 10.1007/s10571-011-9769-z. Epub 2011 Nov 12.

PMID:
22080356
20.

Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.

Satoh J, Tabunoki H, Ishida T, Yagishita S, Jinnai K, Futamura N, Kobayashi M, Toyoshima I, Yoshioka T, Enomoto K, Arai N, Arima K.

Neuropathology. 2011 Aug;31(4):363-75. doi: 10.1111/j.1440-1789.2010.01174.x. Epub 2010 Dec 1.

PMID:
21118401
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk